What question did this study set out to answer?

The study aims to investigate how DS96432529 influences osteogenic differentiation and inflammatory damage in periodontal ligament stem cells (PDLSCs).

March 23, 2026Open Access

DS96432529 enhances osteogenic differentiation and mitigates inflammatory damage in periodontal ligament stem cells involving mitophagy-related processes

Key Points

The study aims to investigate how DS96432529 influences osteogenic differentiation and inflammatory damage in periodontal ligament stem cells (PDLSCs).
Evaluated the osteogenic potential of PDLSCs treated with DS96432529
Assessed mitophagy-related processes
Analyzed the RIG-I-mediated RLR signaling pathway
DS96432529 significantly enhances the osteogenic differentiation of PDLSCs
It reduces inflammatory damage associated with osteogenesis
Increased activity of mitophagy-related processes was observed

Abstract

DS enhances the osteogenic potential of PDLSCs in association with the activation of mitophagy-related processes. It mitigates inflammation-impaired osteogenesis, potentially via modulation of the RIG-I-mediated RLR signaling pathway, in association with increased mitophagy-related activity. DS represents a potent therapeutic small molecule for ameliorating periodontitis-induced bone loss.

Bookmark

View Full Paper